help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veeranna
Right arrow Articles by Nixon, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veeranna,
Right arrow Articles by Nixon, R. A.
(American Journal of Pathology. 2004;165:795-805.)
© 2004 American Society for Investigative Pathology

Calpain Mediates Calcium-Induced Activation of the Erk1,2 MAPK Pathway and Cytoskeletal Phosphorylation in Neurons

Relevance to Alzheimer’s Disease

Veeranna*{dagger}, Takahide Kaji{ddagger}, Barry Boland*{dagger}, Tatjana Odrljin*, Panaiyur Mohan*{dagger}, Balapal S. Basavarajappa§, Corrinne Peterhoff*, Anne Cataldo, Anna Rudnicki, Niranjana Amin||, Bing Sheng Li||, Harish C. Pant||, Basalingappa L. Hungund§, Ottavio Arancio*{dagger} and Ralph A. Nixon*{dagger}**

From the Center for Dementia Research,* Nathan Kline Institute for Psychiatric Research, Orangeburg, New York; the Department of Psychiatry,{dagger} New York University School of Medicine, New York, New York; the Department of Cell Biology,** New York University School of Medicine, New York, New York; the Division of Analytical Psychopharmacology,§ New York State Psychiatric Institute and Nathan Kline Institute for Psychiatric Research, Orangeburg, New York; Mitsubishi-Tokyo Pharmaceuticals,{ddagger} Inc., Yokohama, Japan; McLean Hospital, Belmont, Massachusetts; and the Laboratory of Neurochemistry,|| National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland

Aberrant phosphorylation of the neuronal cytoskeleton is an early pathological event in Alzheimer’s disease (AD), but the underlying mechanisms are unclear. Here, we demonstrate in the brains of AD patients that neurofilament hyperphosphorylation in neocortical pyramidal neurons is accompanied by activation of both Erk1,2 and calpain. Using immunochemistry, Western blot analysis, and kinase activity measurements, we show in primary hippocampal and cerebellar granule (CG) neurons that calcium influx activates calpain and Erk1,2 and increases neurofilament phosphorylation on carboxy terminal polypeptide sites known to be modulated by Erk1,2 and to be altered in AD. Blocking Erk1,2 activity either with antisense oligonucleotides to Erk1,2 mRNA sequences or by specifically inhibiting its upstream activating kinase MEK1,2 markedly reduced neurofilament phosphorylation. Calpeptin, a cell-permeable calpain inhibitor, blocked both Erk1,2 activation and neurofilament hyperphosphorylation at concentrations that inhibit calpain-mediated cleavage of brain spectrin. By contrast, inhibiting Erk1,2 with U-0126, a specific inhibitor of Mek1,2, had no appreciable effect on ionomycin-induced calpain activation. These findings demonstrate that, under conditions of calcium injury in neurons, calpains are upstream activators of Erk1,2 signaling and are likely to mediate in part the hyperphosphorylation of neurofilaments and tau seen at early stages of AD as well as the neuron survival-related functions of the MAP kinase pathway.





This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. V. Rao, P. S. Mohan, C. M. Peterhoff, D.-S. Yang, S. D. Schmidt, P. H. Stavrides, J. Campbell, Y. Chen, Y. Jiang, P. A. Paskevich, et al.
Marked Calpastatin (CAST) Depletion in Alzheimer's Disease Accelerates Cytoskeleton Disruption and Neurodegeneration: Neuroprotection by CAST Overexpression
J. Neurosci., November 19, 2008; 28(47): 12241 - 12254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. S. Moshal, M. Singh, U. Sen, D. S. E. Rosenberger, B. Henderson, N. Tyagi, H. Zhang, and S. C. Tyagi
Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2825 - H2835.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. H. Chong, Y. J. Shin, E. O. Lee, R. Kayed, C. G. Glabe, and A. J. Tenner
ERK1/2 Activation Mediates Abeta Oligomer-induced Neurotoxicity via Caspase-3 Activation and Tau Cleavage in Rat Organotypic Hippocampal Slice Cultures
J. Biol. Chem., July 21, 2006; 281(29): 20315 - 20325.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Liu, I. Grundke-Iqbal, K. Iqbal, Y. Oda, K. Tomizawa, and C.-X. Gong
Truncation and Activation of Calcineurin A by Calpain I in Alzheimer Disease Brain
J. Biol. Chem., November 11, 2005; 280(45): 37755 - 37762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Kelly, R. Vassar, and A. Ferreira
{beta}-Amyloid-induced Dynamin 1 Depletion in Hippocampal Neurons: A POTENTIAL MECHANISM FOR EARLY COGNITIVE DECLINE IN ALZHEIMER DISEASE
J. Biol. Chem., September 9, 2005; 280(36): 31746 - 31753.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S.-Y. Park and A. Ferreira
The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates {beta}-Amyloid-Induced Neurodegeneration
J. Neurosci., June 1, 2005; 25(22): 5365 - 5375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.